Table 1. Examined human cases.
| Case | Disease | Staging (Braak& Braak, CERAD) | Age, yr/Sex | PI | AT8 Retina |
| 1 | AD | VI, C | 39/M | 7 h | + |
| 2 | AD | VI, C | 73/F | 20 h | + |
| 3 | AD | VI, C | 85/M | 27 h | + |
| 4 | AD | VI, C | 56/F | 22 h | + |
| 5 | AD | VI, C | 37/M | 24 h | + |
| 6 | AD | V, C | 79/M | 72 h | − |
| 7 | PSP | - | 67/M | 40 h | ++ |
| 8 | PSP | - | 84/F | 8 h | ++ |
| 9 | Control | 0 | 53/M | 24 h | − |
| 10 | Control | 0 | 56/M | 72 h | − |
| 11 | Control | I | 60/W | 18 h | − |
| 12 | Control | I | 57/M | 16 h | − |
AD, Alzheimer's disease; F, female; M, male; PI, post mortem interval; PSP, Progressive supranuclear palsy; −, no AT8-positive cells; +, occasional AT8-positive cells; ++, many AT8-positive cells.